DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 USDMF, 1 NDC API, 1 Listed Suppliers

2 API Suppliers
2 USDMF
1 NDC API
1 Listed Suppliers

MARKET PLACE

1 APIs

marketPlace
1 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 121915-83-1, Rph56vwa1a, Sq 33,248, Sq-33248, Calteridol calcium (usan), Calteridol calcium [usan]

Molecular Formula

C₃₄H₅₈Ca₃N₈O₁₄

Molecular Weight

923.1 g/mol

InChI Key

LIUKFIPDXXYGSI-UHFFFAOYSA-H

FDA UNII

RPH56VWA1A

1 2D Structure

Calteridol Calcium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

tricalcium;2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate

2.1.2 InChI

InChI=1S/2C17H32N4O7.3Ca/c2*1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;;;/h2*14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);;;/q;;3*+2/p-6

2.1.3 InChI Key

LIUKFIPDXXYGSI-UHFFFAOYSA-H

2.1.4 Canonical SMILES

CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Ca+2].[Ca+2].[Ca+2]

2.2 Other Identifiers

2.2.1 UNII

RPH56VWA1A

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 121915-83-1

2. Rph56vwa1a

3. Sq 33,248

4. Sq-33248

5. Calteridol Calcium (usan)

6. Calteridol Calcium [usan]

7. Tricalcium;2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate

8. Unii-rph56vwa1a

9. Calteridol Calcium [usan:ban]

10. Calteridol Calcium [ii]

11. Chembl2106555

12. Calteridol Calcium [vandf]

13. Calteridol Calcium [who-dd]

14. (+-)-calcium Bis((10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))calciate(1-))

15. D03320

16. Q27288232

17. (+/-)-calcium Bis((10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))calciate(1-))

18. Calciate(1-), (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n(sup 1),n(sup 4),n(sup 7),n(sup 10),o(sup 1),o(sup 4),o(sup 7),o(sup 10))-, Calcium (2:1)

19. Calciate(1-), (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n(sup 1),n(sup 4,n(sup 7),n(sup 10),o(sup 1),o(sup 4),o(sup 7),o(sup 10))-, Calcium (2:1)

2.4 Create Date

2006-11-22

3 Chemical and Physical Properties

Molecular Formula	C₃₄H₅₈Ca₃N₈O₁₄
Molecular Weight	923.1 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	22
Rotatable Bond Count	10
Exact Mass	922.2950211 g/mol
Monoisotopic Mass	922.2950211 g/mol
Topological Polar Surface Area	307 Å²
Heavy Atom Count	59
Formal Charge	0
Complexity	471
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	5